BRIEF-Gilead says European Commission gives marketing nod for HIV-1 treatment
November 18, 2013 at 08:13 AM EST
Nov 18 (Reuters) - Gilead Sciences Inc : * European Commission grants marketing authorization for Vitekta tablets for
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.